Detection of Shiga toxin-producing (STEC) presenting high risk of human infections is challenging. In France, the latest Anses opinion categorized STEC in four groups based on their association with severe forms of clinical infection. STEC strains carrying the gene, particularly those of serogroups O157, O26, O111, O103, O145, O121, O45 and more recently O80 (top 8 serogroups), are usually monitored worldwide, whereas -negative STEC strains that are less clinically significant are not surveyed. Screening food enrichment broths with classical genetic markers (, ) can overestimate the presence of highly virulent STEC, causing needless disruption and costs for food producers. Recently the updated MLG5C reference method introduced additional genetic markers (, ) in the detection scheme to improve specificity and effectiveness of priority STEC detection in foodstuffs. This study, conducted on beef samples with a new method supporting the regulatory USDA-FSIS MLG5C.04 method, showed that 92% of the -positive samples carry alone or in association with . Among the -positive samples, and/or subtypes dominate. Introduction of , markers on 868 / beef enrichment broths reduced the number of presumptive positive results by 31%, compared to the ISO/TS 13136:2012 reference method. Subsequent analysis of the presumptive positives combining the O-group and the -subtype provided also a significant reduction of the number of the presumptive positive for the top 8 -positive STEC serogroups; and showed that O26, O103 and O157 were the most prevalent ones. Regarding the / samples, which are proportionally extremely predominant in beef as compared with the / samples, 65% of them were positive for the serogroups monitored in this study (O91, O171, O174, O148, O146, O128 O113 and O104). The high occurrence of serogroup O113 observed in beef samples is not corroborated by the clinical data reported in France. Routine testing of beef samples should be revised to prioritize a hierarchical surveillance system based only on high risk STEC (STEC carrying the gene) and not on all STEC. This approach would provide Food Business Operators a significant improvement, saving time and costs while maintaining a high level of product safety.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11860885 | PMC |
http://dx.doi.org/10.3389/fmicb.2025.1543686 | DOI Listing |
PLoS One
March 2025
Department of Medicine, University of Wisconsin Hospitals and Clinics, Madison, Wisconsin, United States of America.
Introduction: Infectious diarrheal diseases are one of the leading causes of worldwide morbidity and mortality. The incidence of diarrhea is higher in Low-Middle-Income Countries (LMIC), where more than 90% of deaths from diarrheal diseases occur. Diagnostic tests for infectious diarrhea are not readily available in Low-Middle-Income Countries.
View Article and Find Full Text PDFBMC Pediatr
March 2025
Institute of Pediatrics, Faculty of Medicine, University of Debrecen, Nagyerdei Krt 98, 4028, Debrecen, Hungary.
Background: Hemolytic uremic syndrome (HUS), characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute kidney injury (AKI), remains a leading cause of pediatric AKI. The complement system has a crucial role in the pathogenesis of atypical hemolytic uremic syndrome (aHUS) and eculizumab (ECZ) was approved as standard of care for its treatment. The two widely characterized forms of infection-associated HUS are Shiga toxin-producing E.
View Article and Find Full Text PDFInt J Med Microbiol
March 2025
Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Ås, Norway. Electronic address:
The global rise of hybrid Escherichia coli (E. coli) is a major public health concern, as enhanced virulence from multiple pathotypes complicates the traditional E. coli classification system and challenges clinical diagnostics.
View Article and Find Full Text PDFJ Pediatric Infect Dis Soc
March 2025
Kaiser Permanente Northern California Pediatrics, Division Infectious Diseases, San Francisco, CA.
Background: Hemolytic uremic syndrome (HUS) is life-threatening sequelae of Shiga toxin producing Escherichia coli (STEC) enteric infection. To address ambiguity in medical literature, we aimed to identify which STEC toxin profiles and clinical variables were at highest risk of HUS progression to inform evidence-based screening guidelines.
Methods: This was a 5-year retrospective study of children aged <18 years with E.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!